ViroGates Past Earnings Performance
Past criteria checks 0/6
ViroGates has been growing earnings at an average annual rate of 11.6%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 20.3% per year.
Key information
11.6%
Earnings growth rate
18.5%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 20.3% |
| Return on equity | -141.0% |
| Net Margin | -190.3% |
| Next Earnings Update | 07 Nov 2024 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How ViroGates makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 7 | -13 | 12 | 6 |
| 31 Mar 24 | 7 | -13 | 12 | 7 |
| 31 Dec 23 | 7 | -12 | 12 | 6 |
| 30 Sep 23 | 9 | -11 | 12 | 7 |
| 30 Jun 23 | 11 | -11 | 12 | 9 |
| 31 Mar 23 | 13 | -10 | 12 | 10 |
| 31 Dec 22 | 15 | -10 | 13 | 11 |
| 30 Sep 22 | 14 | -12 | 14 | 10 |
| 30 Jun 22 | 12 | -13 | 16 | 8 |
| 31 Mar 22 | 9 | -16 | 18 | 7 |
| 31 Dec 21 | 8 | -18 | 19 | 7 |
| 30 Sep 21 | 7 | -18 | 19 | 6 |
| 30 Jun 21 | 8 | -18 | 19 | 6 |
| 31 Mar 21 | 7 | -17 | 17 | 6 |
| 31 Dec 20 | 5 | -19 | 18 | 6 |
| 30 Sep 20 | 4 | -21 | 19 | 5 |
| 30 Jun 20 | 2 | -21 | 19 | 5 |
| 31 Mar 20 | 3 | -21 | 19 | 6 |
| 31 Dec 19 | 4 | -19 | 17 | 6 |
| 30 Sep 19 | 4 | -16 | 24 | 9 |
| 30 Jun 19 | 4 | -14 | 22 | 7 |
| 31 Mar 19 | 4 | -18 | 7 | 0 |
| 31 Dec 18 | 3 | -17 | 17 | 4 |
| 30 Sep 18 | 3 | -15 | 5 | 0 |
| 30 Jun 18 | 3 | -14 | 5 | 0 |
| 31 Mar 18 | 2 | -7 | 4 | 0 |
| 31 Dec 17 | 2 | -6 | 3 | 0 |
| 31 Dec 16 | 4 | -5 | 3 | 0 |
| 31 Dec 15 | 4 | -4 | 4 | 0 |
Quality Earnings: EP2 is currently unprofitable.
Growing Profit Margin: EP2 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EP2 is unprofitable, but has reduced losses over the past 5 years at a rate of 11.6% per year.
Accelerating Growth: Unable to compare EP2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EP2 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: EP2 has a negative Return on Equity (-140.96%), as it is currently unprofitable.